Cited by 131Menstrual Health and DisordersPlatelet Disorders and TreatmentsNeurotransmitter Receptor Influence on Behavior

The DOI matches its Crossref record.

Serotonin Levels and Platelet Uptake during Premenstrual Tension

Taylor, Dorothy L., Mathew, Roy J., Ho, Beng T., Weinman, Maxine L.·2008·Neuropsychobiology

DOI 10.1159/000118103

Open this paper in CoChat — free account

Abstract

Premenstrual tension was studied in 16 females, using both biochemical and psychological parameters during the pre- and postmenstrual phases. Uptake of serotonin (5-HT) and the levels of 5-HT in platelet-rich plasma and platelet-poor plasma were determined. Degrees of distress experienced pre- and postmenstrually were quantified via the Moos menstrual distress questionnaire. The mean V max was significantly lower during the premenstrual (tension) phase (8.2 ± 0.9 pmol/min) as compared to the postmenstrual (normal) phase (14.4 ± 3.2 pmol/min). There was no significant difference in the K m values. A highly significant (p < 0.001) reduction in the levels of 5-HT in platelet-rich plasma (–23.2%) and platelet-poor plasma (-19.1%) was found during the premenstrual phase. There were correlations between the kinetic parameters of 5-HT uptake and some of the Moos symptoms.

Integrity signals

Registry

Crossref · 10.1159/000118103

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

The lower limb flexion reflex in humans
Sandrini, G., Serrao, M., Rossi, P., Romaniello, A., Cruccu, G., & Willer, J. C. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.11.003 · Cited by 508
Selective serotonin reuptake inhibitors for premenstrual syndrome.
Marjoribanks, J., Brown, J., O'Brien, P., & Wyatt, K. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001396.pub3 · Cited by 180
The etiology, biology, and evolving pathology of premenstrual syndromes
Halbreich, U. M. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00097-0 · Cited by 310
Menstrual cycle and appetite control: implications for weight regulation
Dye, L., & Blundell, J. E. (1997) · Human Reproduction · doi:10.1093/humrep/12.6.1142 · Cited by 304
“The more premenstrually (Taylor et al., 1984; Tam et al., 1985).”
Sleep, hormones, and circadian rhythms throughout the menstrual cycle in healthy women and women with premenstrual dysphoric disorder
Shechter, A., & Boivin, D. B. (2010) · International Journal of Endocrinology · doi:10.1155/2010/259345 · Cited by 194
“Experimental evidence implicating the serotonergic system includes findings of reduced plasma- [101] and whole-blood [102] serotonin levels in patients compared to controls.”
Background
An engineered IL-2 partial agonist promotes CD8+ T cell stemness
Mo, F., Yu, Z., Li, P., Oh, J., Spolski, R. J., Zhao, L., Glassman, C. R., Yamamoto, T. N., Chen, Y., Gołębiowski, F., et al. (2021) · Nature · doi:10.1038/s41586-021-03861-0 · Cited by 178
Depression and weight gain: the serotonin connection
Wurtman, J. J. (1993) · Journal of Affective Disorders · doi:10.1016/0165-0327(93)90032-f · Cited by 149
Venlafaxine in the treatment of premenstrual dysphoric disorder*1
Freeman, E. W. (2001) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(01)01530-7 · Cited by 128
Alteration of platelet serotonergic mechanisms and monoamine oxidase activity in premenstrual syndrome
Ashby, C. R., Carr, L. A., Cook, C. L., Steptoe, M. M., & Franks, D. D. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90277-6 · Cited by 122
Selective serotonin reuptake inhibitors for premenstrual syndrome
Brown, J., O’Brien, P. M. S., Marjoribanks, J., & Wyatt, K. M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001396.pub2 · Cited by 115
Premenstrual dysphoric disorder and psychiatric co-morbidity
Kim, D. R., Gyulai, L., Freeman, E. W., Morrison, M. F., Baldassano, C. F., & Dub�, B. (2004) · Archives of Women s Mental Health · doi:10.1007/s00737-003-0027-3 · Cited by 108
Premenstrual syndrome, a common but underrated entity: review of the clinical literature
Dilbaz, B., & Aksan, A. (2021) · Journal of the Turkish-German Gynecological Association · doi:10.4274/jtgga.galenos.2021.2020.0133 · Cited by 129
“Current evidence suggests that PMS is a disorder triggered by changes in gonadal steroids during the LPMC in susceptible women.”
BackgroundInfluential
The premenstrual syndrome – a reappraisal of the concept and the evidence
Bancroft, J. (1993) · Psychological Medicine Monograph Supplement · doi:10.1017/s0264180100001272 · Cited by 102
Premenstrual dysphoric disorder as a correlate of suicidal ideation, plans, and attempts among a nationally representative sample
Pilver, C. E., Libby, D. J., & Hoff, R. A. (2012) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-012-0548-z · Cited by 85
“Correspondingly, researchers have noted that in the premenstrual phase, women with PMDD have lower whole blood serotonin levels and lower platelet serotonin uptake than women without PMDD [30, 31].”
A controlled study of light therapy in women with late luteal phase dysphoric disorder
Lam, R. W., Carter, D., Misri, S., Kuan, A. J., Yatham, L. N., & Zis, A. P. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00043-8 · Cited by 85
“Other studies indicate dysregulation of seroŽtonergic function in LLPDD Taylor et al., 1984; Rapkin et al., 1987; Halbreich and Tworek, 1993; .”
Background
The Efficacy of Hypericum perforatum (St Johnʼs Wort) for the Treatment of Premenstrual Syndrome
Canning, S. E., Waterman, M. G., Orsi, N. M., Ayres, J., Simpson, N., & Dye, L. (2010) · CNS Drugs · doi:10.2165/11530120-000000000-00000 · Cited by 89
Changes in Nociceptive Flexion Reflex Threshold Across the Menstrual Cycle in Healthy Women
Tassorelli, C., Sandrini, G., Cecchini, A. P., Nappi, R. E., Sances, G., & Martignoni, E. (2002) · Psychosomatic Medicine · doi:10.1097/01.psy.0000021945.35402.0d · Cited by 83
Full- or Half-Cycle Treatment of Severe Premenstrual Syndrome With a Serotonergic Antidepressant
Freeman, E. W., Rickels, K., Arredondo, F., Kao, L.-C., Pollack, S. E., & Sondheimer, S. J. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199902000-00002 · Cited by 75
Evaluation and Management of Premenstrual Syndrome and Premenstrual Dysphoric Disorder
Frackiewicz, E. J., & Shiovitz, T. M. (2001) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(16)31257-8 · Cited by 68
Personality Traits of Suicidality Are Associated with Premenstrual Syndrome and Premenstrual Dysphoric Disorder in a Suicidal Women Sample
Ducasse, D., Jaussent, I., Olié, É., Guillaume, S., López‐Castromán, J., & Courtet, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148653 · Cited by 63
Luteal Phase Administration of Agents for the Treatment of Premenstrual Dysphoric Disorder
Freeman, E. W. (2004) · CNS Drugs · doi:10.2165/00023210-200418070-00004 · Cited by 63
PREMENSTRUAL SYNDROMES
Steiner, M. S. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.447 · Cited by 63
Serotonin, Carbohydrates, and Atypical Depression
Møller, S. E. (1992) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1992.tb01630.x · Cited by 62
Advances in the Diagnosis and Treatment of Premenstrual Dysphoria
Steiner, M. S., & Born, L. (2000) · CNS Drugs · doi:10.2165/00023210-200013040-00005 · Cited by 56
The Role of Central Serotonergic Dysfunction in the Aetiology of Premenstrual Dysphoric Disorder
Parry, B. L. (2001) · CNS Drugs · doi:10.2165/00023210-200115040-00003 · Cited by 54
The Influence of Serotonin Deficiency on Choice Deferral and the Compromise Effect
Lichters, M., Brunnlieb, C., Nave, G., Sarstedt, M., & Vogt, B. (2015) · Journal of Marketing Research · doi:10.1509/jmr.14.0482 · Cited by 53
“…that marketing strategies that systematically incorporate the compromise effect with the intent to promote the choice of an intermediate compromise option might be less effective when the target population’s serotonin levels are lowered (e.g., at old age or duringwinter; Taylor et al. 1984).”
Background
Cerebrospinal Fluid Levels of Monoamine Metabolites
Eriksson, E., Alling, C., Andersch, B., Andersson, K., & Berggren, U. (1994) · Neuropsychopharmacology · doi:10.1038/sj.npp.1380107 · Cited by 54
Electrophysiological findings during the menstrual cycle in women with and without late luteal phase dysphoric disorder: relationship to risk for alcoholism?
Ehlers, C. L., Phillips, E., & Parry, B. L. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00183-2 · Cited by 49
Models for the Development and Expression of Symptoms in Premenstrual Syndrome
Rubinow, D. R., & Schmidt, P. J. (1989) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30451-9 · Cited by 47
Selective serotonin reuptake inhibitors for premenstrual syndrome
Brown, J., O’Brien, P. M. S., Marjoribanks, J., & Wyatt, K. M. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001396 · Cited by 46
Chinese herbal medicine for premenstrual syndrome
Jing, Z., Yang, X., ISMAIL, K. M. K., Chen, X. Y., & Wu, T. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006414.pub2 · Cited by 46
IgA/IgM responses to tryptophan and tryptophan catabolites (TRYCATs) are differently associated with prenatal depression, physio-somatic symptoms at the end of term and premenstrual syndrome
Roomruangwong, C., Kanchanatawan, B., Sirivichayakul, S., Anderson, G., Carvalho, A. F., Duleu, S., Geffard, M., & Maes, M. H. J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9877-3 · Cited by 41
Depression and Its Effect on the Menstrual Cycle
Padda, J., Khalid, K., Hitawala, G., Batra, N., Pokhriyal, S. C., Mohan, A., Zubair, U., Cooper, A. C., & Jean-Charles, G. (2021) · Cureus · doi:10.7759/cureus.16532 · Cited by 45
Memory function in women with premenstrual complaints and the effect of serotonergic stimulation by acute administration of an alpha-lactalbumin protein
Schmitt, J. A. J., Jorissen, B. L., Dye, L., Markus, C. R., Deutz, N. E. P., & Riedel, W. J. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105053288 · Cited by 43
Serotonin transporter gene polymorphisms and platelet [3H] paroxetine binding in premenstrual dysphoria
Melke, J., Westberg, L., Landén, M., et al. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00033-1 · Cited by 42
“, 1992), as well as studies reporting reduced platelet uptake of serotonin in women with PMD (Taylor et al., 1984; Ashby et al., 1988).”
Background
Reduced platelet tritium-labeled imipramine binding sites in women with premenstrual syndrome
Steege, J. F., Stout, A. L., Knight, D. L., et al. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(11)91653-6 · Cited by 42
Is 5HT 1A Receptor Subsensitivity a Trait Marker for Late Luteal Phase Dysphoric Disorder? A Pilot Study
Yatham, L. N. (1993) · The Canadian Journal of Psychiatry · doi:10.1177/070674379303801007 · Cited by 42
“decreased 5-HT uptake into platelets (2,3); and 3.”
Background
Neuroendocrine response to an intravenous L-tryptophan challenge in women with premenstrual syndrome
Rasgon, N., McGuire, M. T., Tanavoli, S., Fairbanks, L. A., & Rapkin, A. J. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00452-5 · Cited by 41
Premenstrual Syndrome and Exercise: A Narrative Review
Sanchez, B. N., Kraemer, W. J., & Maresh, C. M. (2023) · Women · doi:10.3390/women3020026 · Cited by 47
A biopsychosocial approach to premenstrual dysphoric disorder
Ross, L. E., & Steiner, M. S. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(03)00035-2 · Cited by 38
“PMDD patients have lower whole blood serotonin levels [44] and lower platelet serotonin uptake [45] during the premenstrual phase.”
Background
Premenstrual dysphoric disorder: a review for the treating practitioner.
Kaur, G., Gonsalves, L., & Thacker, H. L. (2004) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.71.4.303 · Cited by 36
Neuroactive steroid-serotonergic interaction: responses to an intravenous L-tryptophan challenge in women with premenstrual syndrome
Rasgon, N., Serra, M., Biggio, G., Pisu, M. G., Fairbanks, L. A., Tanavoli, S., & Rapkin, A. J. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450025 · Cited by 35
“Subsequently other investigators have demonstrated decreased platelet uptake of serotonin in women with PMS ( 2 ) and there are numerous reports that administration of SSRIs and other serotonergic agonists leads to improvement in the symptoms of PMS/PMDD (3, 4, 22, 23).”
BackgroundResultInfluential
Treatment of depression associated with the menstrual cycle: premenstrual dysphoria, postpartum depression, and the perimenopause
Freeman, E. W. (2002) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2002.4.2/efreeman · Cited by 35
Effective open‐label treatment of premenstrual dysphoric disorder with venlafaxine
Hsiao, M., & Liu, C. (2003) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.2003.01123.x · Cited by 33
Alteration of 5-HT uptake by plasma fractions in the premenstrual syndrome
Ashby, C. R., Carr, L. A., Cook, C. L., Steptoe, M. M., & Franks, D. D. (1990) · Journal of Neural Transmission · doi:10.1007/bf01250999 · Cited by 33
Menstrual cycle effects on the metabolism of tryptophan loads
Hrboticky, N., Leiter, L. A., & Anderson, G. H. (1989) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/50.1.46 · Cited by 32
Serotonin and gender-specific psychiatric disorders
Steiner, M. S., Lepage, P., & Dunn, E. J. (1997) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651509709069200 · Cited by 30
A Risk-Benefit Appraisal of Drugs Used in the Management of Premenstrual Syndrome
Mortola, J. F. (1994) · Drug Safety · doi:10.2165/00002018-199410020-00005 · Cited by 30
Venlafaxine in the Treatment of Premenstrual Dysphoric Disorder
Freeman, E. W., Rickels, K., Yonkers, K. A., Kunz, N. R., McPherson, M., & Upton, G. V. (2001) · Obstetrics and Gynecology · doi:10.1097/00006250-200111000-00006 · Cited by 30
Psychiatric evaluation of premenstrual changes
Harrison, W. M., Rabkin, J. G., & Endicott, J. (1985) · Psychosomatics · doi:10.1016/s0033-3182(85)72792-2 · Cited by 29
The menstrual cycle and platelet 5-HT uptake.
Tam, W. Y., Chan, M., & Lee, P. H. (1985) · Psychosomatic Medicine · doi:10.1097/00006842-198507000-00005 · Cited by 28
“(14), we were unable to obtain significant correlation between any of the mood items and platelet 5-HT uptake kinetic parameters.”
BackgroundInfluential
Serotonergic function and late luteal phase dysphoric disorder
Veeninga, A. T., & Westenberg, H. G. M. (1992) · Psychopharmacology · doi:10.1007/bf02245301 · Cited by 27
Serotonin and measured intelligence
Cook, E. H., LEVENTHAL, B. L., & Freedman, D. X. (1988) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02211873 · Cited by 26
Approach to Premenstrual Dysphoria for the Mental Health Practitioner
Vigod, S. N., Frey, B. N., Soares, C. N., & Steiner, M. S. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2010.01.008 · Cited by 25
Pharmacotherapy of premenstrual syndromes and premenstrual disphoric disorder: current practices
Mitwally, M. F., Kahn, L. S., & Halbreich, U. M. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.11.1577 · Cited by 25
“Serotonergic dysfunction in PMS also has been suggested on the basis of findings of decreased platelet uptake of serotonin [23], blunted response to 5-HT agonists [24] and consistent therapeutic efficacy of selective serotonergic re-uptake inhibitors (SSRIs) in the treatment of this disorder [25-27].”
Background
Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment
Bixo, M., Allard, P. O., Bäckström, T. C., et al. (2001) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(01)00010-5 · Cited by 24
“, 1994), the present findings should indirectly implicate increased uptake of 5-HT, contradictory to findings of decreased premenstrual uptake of 5-HT into platelets in PMDD (Taylor et al., 1984; Ashby et al., 1988).”
Result
Dissociative Experiences and Eating Disorders
Goldner, E. M., Cockhill, L. A., Bakan, R., & Birmingham, C. L. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.9.1274-b · Cited by 24
Premenstrual dysphoric disorder and suicide attempts as a correlation among women in reproductive age
Shams‐Alizadeh, N., Maroufi, A., Rashidi, M., Roshani, D., Farhadifar, F., & Khazaie, H. (2018) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2018.01.003 · Cited by 22
Exploratory study of premenstrual symptoms and serotonin variability
Clayton, A. H., Keller, A. E., Leslie, C. E., & Evans, W. (2005) · Archives of Women s Mental Health · doi:10.1007/s00737-005-0118-4 · Cited by 22
“The second showed a decreased Vmax of 5-HT uptake and 5-HT content in the platelets of PMS patients (Taylor et al, 1984).”
Background
Decreased central opioid activity in premenstrual syndrome: Luteinizing hormone response to naloxone
Rapkin, A. J., Shoupe, D., Reading, A. E., et al. (1996) · Journal of the Society for Gynecologic Investigation · doi:10.1016/1071-5576(95)00045-3 · Cited by 22
Pain Sensitivity in Women with Premenstrual Dysphoric Disorder: A Preliminary Report
Fillingim, R. B., Girdler, S. S., Booker, D., Light, K. C., Harris, M. B., & Maixner, W. D. (1995) · Journal of Women s Health · doi:10.1089/jwh.1995.4.367 · Cited by 21
“Similarly, some studies report impaired serotonergic function premenstrually in PDD sufferers compared with controls,14-16 while others do not support the serotonin hypothesis.17'18 Thus, the etiology of PDD remains unclear.”
Serotonin (5‐HT) uptake by blood platelets in anorexia nervosa
Zemishlany, Z., Modai, I., Apter, A. S., et al. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb02763.x · Cited by 21
Le syndrome prémenstruel: revue générale
Zaafrane, F., Faleh, R., Melki, W., Sakouhi, M., & Gaha, L. (2007) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/j.jgyn.2007.01.007 · Cited by 20
Circadian and circatrigintan rhythms of biogenic amines in premenstrual syndrome (PMS).
Odink, J., van der Ploeg, H. M., van den Berg, H., et al. (1990) · Psychosomatic Medicine · doi:10.1097/00006842-199005000-00008 · Cited by 20
“Although Malmgren et al. (34) did not observe differences between PMS patients and control subjects in serotonin uptake by platelets, the results of several studies ( 35-38 ) indicate a reduced peripheral serotonin metabolism in PMS and are thus suggestive of a reduced central serotonergic activity.”
Result
Progesterone, GABA and mood disorders in women
Rapkin, A. J. (1999) · Archives of Women s Mental Health · doi:10.1007/s007370050041 · Cited by 19
“Decreased platelet uptake of serotonin and decreased whole blood serotonin have all been documented in individuals with major depressive disorder and PMS (Meltzer, 1990; LeQuan-Bui et al., 1984; Lopez-Ibor, 1988; Taylor et al., 1984; Rapkin et al., 1987).”
Background
Abnormal platelet 5-hydroxytryptamine uptake and imipramine binding in postnatal dysphoria
Hannah, P., Adams, D., Glover, V. A. S., & Sandler, M. (1992) · Journal of Psychiatric Research · doi:10.1016/0022-3956(92)90017-i · Cited by 18
Understanding and Treating Premenstrual Dysphoric Disorder: An Update for the Women's Health Practitioner
Vigod, S. N., Ross, L. E., & Steiner, M. S. (2009) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2009.10.010 · Cited by 18
Evaluation of drug-induced injury and human response in precision-cut tissue slices
Vickers, A. E. M., & Fisher, R. L. (2012) · Xenobiotica · doi:10.3109/00498254.2012.732714 · Cited by 18
Pharmacological Management of Premenstrual Disorder
Altshuler, L. L., Hendrick, V. C., & Parry, B. L. (1995) · Harvard Review of Psychiatry · doi:10.3109/10673229509017143 · Cited by 18
Structural and dynamical thermostability of psychrophilic enzyme at various temperatures: Molecular dynamics simulations of tryptophan synthase
Parveen, T., Kamran, M., & Fatmi, M. Q. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.01.022 · Cited by 17
Development and validation of an improved radioimmunoassay for serotonin in platelet-rich plasma
Gow, I. F., Corrie, J. E. T., Williams, B. C., et al. (1987) · Clinica Chimica Acta · doi:10.1016/0009-8981(87)90449-9 · Cited by 17
Treatment of premenstrual dysphoric disorder with luteal phase dosing of sertraline
Halbreich, U. M., & Kahn, L. S. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.11.2065 · Cited by 16
Platelet monoamine oxidase B activity in women with premenstrual syndrome
Rapkin, A. J., Buckman, T. D., Sutphin, M. S., et al. (1988) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(88)90590-x · Cited by 15
Premenstrual Dysphoric Disorder
Elliott, H. (2002) · North Carolina Medical Journal · doi:10.18043/ncm.63.2.72 · Cited by 15
Peripheral measures of arginine vasopressin, atrial natriuretic peptide and adrenocorticotropic hormone in premenstrual syndrome
Rosenstein, D. L., Kalogeras, K. T., Kalafut, M. A., Malley, J. D., & Rubinow, D. R. (1996) · Psychoneuroendocrinology · doi:10.1016/0306-4530(95)00035-6 · Cited by 14
Tryptophan loading test in premenstrual syndrome
Rapkin, A. J., Chung, L., Reading, A. E., et al. (1989) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443618909151136 · Cited by 13
Verapamil treatment of premenstrual syndrome
Deicken, R. F. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90142-4 · Cited by 13
Tryptophan and neutral amino acids in premenstrual syndrome
Rapkin, A. J., Reading, A. E., Woo, S., & Goldman, L. M. (1991) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(91)90040-x · Cited by 12
Tryptophan and its role in sleep and mood
Yousef, P., Rosen, J., & Shapiro, C. M. (2024) · Studies in natural products chemistry · doi:10.1016/b978-0-443-15589-5.00001-3 · Cited by 12
Prämenstruelles Syndrom und prämenstruelle dysphorische Störung – Übersicht zu Pathophysiologie, Diagnostik und Therapie
Haußmann, J., Goeckenjan, M., Haußmann, R., & Wimberger, P. (2024) · Der Nervenarzt · doi:10.1007/s00115-024-01625-5 · Cited by 12
Premenstrual dysphoric disorder: literature review
Fryer, C., Kaspi, S. P., Fallon, S. K., Moline, M. L., & Severino, S. K. (1999) · Archives of Women s Mental Health · doi:10.1007/s007370050031 · Cited by 9
“…2) premenstrual decreased latency to rapid eye movement on sleep EEG (Unden and Christensen 1986), 3) luteal phase decrease in plasma B-endorphin (Facchinetti et al., 1987, Chuong et al., 1985), and 4) luteal phase decrease in platelet serotonin uptake (Taylor et al., 1984, Ashby et al., 1988).”
Background
Premenstrual syndrome: current knowledge and management.
Robinson, G. E. (1989) · PubMed · Cited by 10
Late luteal phase dysphoric disorder: A scientific puzzle
Severino, S. K. (1993) · Medical Hypotheses · doi:10.1016/0306-9877(93)90236-j · Cited by 9
Premenstrual Syndrome
Severino, S. K., & Moline, M. L. (1990) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(21)00455-1 · Cited by 8
Premenstrual Dysphoric Disorder
Nowakowski, S., Haynes, P. L., & Parry, B. L. (2007) · Elsevier eBooks · doi:10.1016/b978-012373947-6.00304-4 · Cited by 9
The pathophysiologic background for current treatments of premenstrual syndromes
Halbreich, U. M. (2002) · Current Psychiatry Reports · doi:10.1007/s11920-002-0070-1 · Cited by 7
“The decrease of some 5-HT parameters during the symptomatic premenstrual period has been demonstrated for serotonin uptake, which was reduced in women with PMS [25, 26 ] and was lower than in women with no PMS [27,28], in platelets.”
Background
Inhibition of serotonin uptake in rat brain synaptosomes by plasma from patients with premenstrual syndrome
Ashby, C. R., Carr, L. A., Cook, C. L., et al. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90164-u · Cited by 7
Intermittent, luteal phase nefazodone treatment of premenstrual dysphoric disorder
Kodesh, A., Katz, S., Lerner, A., et al. (2001) · Journal of Psychopharmacology · doi:10.1177/026988110101500110 · Cited by 7
Fluoxetine and Preoccupation With Suicide
Balon, R. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.9.1260 · Cited by 7
Comparación entre el tratamiento continuo y el intermitente con citalopram para el trastorno disfórico premenstrual
Ramos, M. F., Uribe, M. O., & Sotres, J. C. (2003) · Salud Mental · Cited by 6
Reflections on the Cause of Premenstrual Syndrome
Halbreich, U. M. (1996) · Psychiatric Annals · doi:10.3928/0048-5713-19960901-11 · Cited by 6
Premenstrual Distress
Collins, A. (1991) · Springer eBooks · doi:10.1007/978-1-4615-3712-0_13 · Cited by 6
9 The premenstrual syndrome: a psychoneuroendocrine perspective
Dinan, T. G., & O’Keane, V. (1991) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80101-6 · Cited by 6
Serotonin re-uptake inhibitors in the treatment of premenstrual dysphoria: Current state of knowledge
Steiner, M. S., Judge, R., & Kumar, R. (1997) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651509709024735 · Cited by 6
Premenstrual syndrome/premenstrual dysphoric disorder
Washington, M., Brown, C., & Ling, F. W. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139628938.004 · Cited by 6
Recognizing and Treating Premenstrual Dysphoric Disorder
Liang, B. A., Batra, P., & Harper, D. M. (2002) · Cited by 5
Premenstrual Dysphoric Disorder
Parry, B. L., Nowakowski, S., Martinez, L. F., & Berga, S. L. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00094-2 · Cited by 4
Premenstrual Syndrome
Dog, T. L. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1793-8.00106-0 · Cited by 4
Gonadal Hormones and Behavior in Women: Concentrations versus Context
Rubinow, D. R., Schmidt, P. J., Meltzer-Brody, S. E., & Harsh, V. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00076-0 · Cited by 4
Non-hormonal therapy of premenstrual syndrome
Martignoni, E., Desideri, S., Sances, G., et al. (1997) · Cephalalgia · doi:10.1177/0333102497017s2007 · Cited by 4

Authors: Taylor, D. L., Mathew, R. J., Ho, B. T., & Weinman, M. L.
ORCID: Weinman, Maxine L.
Venue: Neuropsychobiology
Publisher: S. Karger AG
Published: 2008-02-19
Volume: 12
Issue: 1
Pages: 16-18
ISSN: 0302-282X (ISSN-L)
1423-0224
DOI: 10.1159/000118103
OpenAlex: W2024348642
Cited by: 131
References: 0
Citations by year: 2026: 1 · 2024: 4 · 2023: 1 · 2022: 1 · 2021: 3 · 2019: 2 · 2018: 1 · 2017: 2 · 2016: 5 · 2015: 3 · 2013: 1 · 2012: 5
FWCI: 3.97
Type: journal article
Language: en
Open access: closed
Licence: karger.com/pages/terms-and-conditions (vor)
karger.com/pages/terms-and-conditions (tdm)
Locations: Neuropsychobiology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords: premenstrual syndrome, serotonin, platelet uptake, platelet-rich plasma, platelet-poor plasma, menstrual cycle, menstrual distress, women
MeSH terms: Adolescent, Adult, Blood Platelets, Female, Humans, Kinetics, Premenstrual Syndrome, Serotonin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Serotonin Levels and Platelet Uptake during Premenstrual Tension

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks